.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Second drug approved for improving photoaged skin

March 17, 2003

The FDA recently approved tazarotene (Avage, Allergan) 0.1% cream as an adjunctive agent for use in the palliation of fine facial wrinkling, facial mottled hyper- and hypopigmentation, and benign facial lentigines in patients who use comprehensive skin care and sunlight avoidance programs. Avage became available in pharmacies in January.